NCT04449406Active, not recruiting
Early Detection of Pancreatic Adenocarcinoma (PDAC) Using a Panel of Biomarkers
Early Detection of Pancreatic Adenocarcinoma (PDAC) Using a Panel of Biomarkers (UroPanc)
Source: ClinicalTrials.gov · Last updated 7 Apr 2026
Brief summary (registry, in English)
Urine and blood samples are being collected from patients with and without diseases of the pancreas. These samples will be tested with the aim of developing an accurate way of diagnosing diseases of the pancreas using the results.
- Status (registry)
- Active, not recruiting
- Study type
- Observational
- Enrollment
- 3500 (estimated)
- First submitted
- 5 May 2020
- Start date
- 1 Jan 2020
- Primary completion date
- 31 Aug 2026
- Lead sponsor
- Queen Mary University of London
- Diseases
- Pancreatic cancer
- NCT number
- NCT04449406
What you commit to
- Study type: Observational
- Planned participants: 3500
- From 1 Jan 2020 to the primary completion date, 31 Aug 2026
- 4 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Current or prior treatment (chemotherapy, radiotherapy, surgical resection, biological therapy, and immunotherapy) for any malignancy other than basal cell carcinoma within 5 years of enrolment.
- Asymptomatic participants will be identified through the EUROPAC registry and will fulfil EUROPAC's eligibility criteria.
Who the study is looking for
- Able and willing to give informed consent
- ≥18 years old
- Suspected pancreatic diseases with symptoms including, but not limited to, diarrhoea, back pain, abdominal pain, nausea, vomiting, constipation or new onset diabetes
Age in the registry: 18 years to - · Sex: All · Accepts healthy volunteers
Sites (4)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| EUROPAC study, University of Liverpool Coordinator of this site? Confirm its status | Liverpool | United Kingdom | Unknown status |
| ADEPTS study, University College London Coordinator of this site? Confirm its status | London | United Kingdom | Unknown status |
| Royal London Hospital Coordinator of this site? Confirm its status | London | United Kingdom | Unknown status |
| Imperial College London Coordinator of this site? Confirm its status | London | United Kingdom | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.